News Releases

Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.

Site search

2011

December 12, 2011

Taiho Pharmaceutical Announces Personnel Changes （PDF：214.8 KB）
September 12, 2011

Taiho Pharmaceutical to Launch a New Anti-tumor Agent,
ZOLINZA® capsules 100mg, on September 14
July 22, 2011

Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
- Positive Results of Overall Survival in Patients with Colorectal Cancer Refractory to Standard Chemotherapy -
July 21, 2011

Taiho Pharmaceutical Co., Ltd and Nordic Group BV Enter into a Development and Commercialization Agreement for the recently EMA approved Anti-Cancer Drug Teysuno™ covering the EU and other Selected European Countries
June 09, 2011

MSD K.K. and Taiho Pharmaceutical Co., Ltd. Enter into Distribution Agreement for the Anticancer Compound Vorinostat in Japan（PDF：73.8 KB）
June 08, 2011

Presentation of results of GEST clinical study of TS-1 in patients with advanced pancreatic cancer to the American Society of Clinical Oncology
June 06, 2011

Presentation to the American Society of Clinical Oncology of results of final analysis of a clinical study in patients with unresectable colorectal cancer (FIRIS study)
April 13, 2011

Announcement of License Agreement on a New Antiemetic Combination Agent
March 25, 2011

Announcement of Promotion of Managing Director（PDF：42.5 KB）
March 15, 2011

Teysuno™ (S-1) Receives European Marketing Authorization As Therapy For Advanced Gastric Cancer
January 26, 2011

Taiho Pharmaceutical Announces Results of Gemcitabine and TS-1 Trial (GEST)on Advanced Pancreatic Cancer

News Releases

Select year from the Back Number